Princeton, NJ, United States of America

Xavier Valencia

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Xavier Valencia

Introduction

Xavier Valencia is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of 2 patents, his work focuses on innovative methods that aim to improve patient outcomes.

Latest Patents

Valencia's latest patents include groundbreaking methods for treating systemic lupus erythematosus using a domain antibody directed against CD28. These methods provide a novel approach to treating autoimmune diseases by utilizing domain antibodies that specifically bind to human CD28. The administration cycle may consist of one dose of the domain antibody, which has been shown to reduce symptoms of systemic lupus erythematosus compared to placebo.

Career Highlights

Xavier Valencia is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for complex autoimmune conditions.

Collaborations

Valencia collaborates with esteemed colleagues, including John P. Throup and Steven G. Nadler, to further enhance the impact of his research. Their combined expertise contributes to the innovative solutions being developed in the field.

Conclusion

Xavier Valencia's contributions to the medical field through his patents and collaborations highlight his commitment to improving treatments for autoimmune diseases. His innovative methods represent a significant step forward in patient care and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…